louisbrulenaudet/clinical-trials huggingface dataset:
Clinical trial NCT06389318: Buccal Midazolam Versus Intranasal Dexmedetomidine Plus Oral Chloral Hydrate in Inguinal Hernia Repair
Official title: Comparison Between Buccal Midazolam Versus Intranasal Dexmedetomidine Plus Oral Chloral Hydrate in Reducing Parental Separation Anxiety in Children Undergoing Inguinal Hernia Repair: A Randomized Clinical Trial
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Inguinal Hernia Repair
Keywords: Midazolam
Dexmedetomidine
Chloral Hydrate
Lead sponsor: Benha University
Sponsor class: OTHER
First posted: 2024-04-29
Enrollment: 80
Sex: ALL
Minimum age (years): 2
Maximum age (years): 7
Standard ages: CHILD
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: Group A (40 patients): Children received oral placebo syrup, Group B (40 patients): Children received oral chloral hydrate (Chloral Hydrate mixture)
Primary purpose: PREVENTION

Brief summary: Inguinal hernia surgery is one of the most common surgical procedures in early infancy. Preoperative anxiety remains a vexing issue, and it exists in nearly 50% of pediatric patients

Detailed description: Inguinal hernia surgery is one of the most common surgical procedures in early infancy. Preoperative anxiety remains a vexing issue, and it exists in nearly 50% of pediatric patients.

The administration of sedatives to a child before entering a surgical room is the most common way of reducing the child's distress and allows the child to undergo smooth anesthesia induction.

Chloral hydrate is a widely used sedative for young children undergoing imaging studies, with a high success rate.

Dexmedetomidine is a highly selective alpha-2 agonist for paediatric sedation. It produces sedation like natural non-rapid eye movement sleep and has respiratory-sparing effect.

Eligibility criteria: Inclusion Criteria:

* aged 2 to 7
* American Society of Anaesthesiology (ASA) І and П scheduled for inguinal hernia repair

Exclusion Criteria:

* sensitivity to dexmedetomidine or midazolam,
* infection of the upper respiratory tract,
* severe liver or kidney disease, organ dysfunction,
* cardiac arrhythmia or congenital heart disease

Primary outcomes:
measure: Ramsay sedation score
timeFrame: RSSs were recorded just immediately before and at 10 minutes , 20 minutes , 30 minutes after dosing
Secondary outcomes:
measure: Parental separation anxiety scale
timeFrame: Preoperatively
Other outcomes:
Locations:
city: Banha
country: Egypt
facility: Benha University
Study officials:
affiliation: Anesthesia and surgical ICU department, Faculty of Medicine, Benha University, Egypt
name: Ramy Saleh, MD
role: PRINCIPAL_INVESTIGATOR
References:
Clinical trial NCT05310318: Prognosis of Low-grade Endometrial Stromal Sarcoma
Official title: Surgical and Reproductive Results of Fertility-sparing Treatment for Low-grade Endometrial Stromal Sarcoma: A Retrospective Cohort Study
Study type: OBSERVATIONAL
Overall status: UNKNOWN
Conditions: Low Grade Endometrial Stromal Sarcoma of Uterus (Diagnosis)
Fertility-sparing Surgery
Survival Outcomes
Fertility Outcomes
Recurrence
Hormone Therapy
Adjuvant Therapy
Lead sponsor: Peking Union Medical College Hospital
Sponsor class: OTHER
First posted: 2022-04-04
Enrollment: 1000
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Observational model: COHORT
Time perspective: RETROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Patients accepted surgical treatment with and without fertility-sparing procedures for uterine low-grade endometrial stromal sarcoma.

Brief summary: This study is to investigate the survival outcomes and fertility outcomes in patients with uterine low-grade endometrial stromal sarcoma (LGESS) treated in Peking Union Medical College Hospital. All primary and recurrent LGESS patients will be enrolled. The study will collect retrospectively data consisting of epidemiological characteristics, surgical, medical treatment and adjuvant therapy. Details about recurrence, mortality, pregnancy and obstetrical outcomes are also followed as primary endpoints. Fertility-sparing procedures, including uterine-sparing and ovary-sparing surgeries will be recorded specifically.


Eligibility criteria: Inclusion Criteria:

* Aged 18 years or older
* Confirmed of LGESS
* Acceptance of surgical treatment for LGESS
* With detailed follow-up outcomes

Exclusion Criteria:

- Not meeting all of the inclusion criteria

Primary outcomes:
measure: Progression-free survival
timeFrame: One year
measure: Overall survival
timeFrame: One year
measure: Pregnancy rate
timeFrame: One year
Secondary outcomes:
measure: Miscarriage rate
timeFrame: One year
measure: Full-term pregnancy rate
timeFrame: One year
Other outcomes:
Locations:
city: Beijing
country: China
facility: Lei Li
state: Beijing
Study officials:
affiliation: Peking Union Medical College Hospital
name: Lei Li, M.D.
role: PRINCIPAL_INVESTIGATOR
References:
Clinical trial NCT01046318: A Study of OPC-262 in Patients With Type 2 Diabetes
Official title: A Long-term Study of OPC-262 in Patients With Type 2 Diabetes
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: PHASE3
Conditions: Type 2 Diabetes
Lead sponsor: Kyowa Kirin Co., Ltd.
Sponsor class: INDUSTRY
First posted: 2010-01-11
Enrollment: 100
Sex: ALL
Minimum age (years): 20
Maximum age (years): 74
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NON_RANDOMIZED
Intervention model: SINGLE_GROUP
Primary purpose: TREATMENT

Brief summary: The purpose of this clinical study is to evaluate the safety and efficacy of OPC-262 5 mg in patients with type 2 diabetes by repeated administration orally for 52 weeks.


Eligibility criteria: Inclusion Criteria:

1. Type 2 diabetes patients with HbA1C above 6.5% and below 10% at both of the time of the 1st and the 2nd screening examinations and who have been undergoing diet and exercise therapies only for at least 8 weeks prior to the 1st screening examination
2. Patients who are capable of giving informed consent
3. Patients who are able to take contraceptive measures to avoid pregnancy of the patient or the patient's partner for the entire study period and for 4 weeks after the study (end of the post-observation period)

Exclusion Criteria:

1. Patients with type 1 diabetes mellitus, patients with diabetes mellitus due to other specified drugs, mechanisms or diseases, and patients with gestational diabetes mellitus
2. Patients with a medical history of diabetic coma
3. Patients with poorly-controlled hypertension
4. Patients with heart failure
5. Patients with a complication of active hepatitis or hepatic cirrhosis
6. Patients undergoing treatment of glomerular diseases other than diabetic nephropathy
7. Patients with a history or complication of malignant tumor

Primary outcomes:
measure: Changes in HbA1C from baseline to each visit (OC) and Week 52 (LOCF)
timeFrame: each visit (OC) and Week 52 (LOCF)
measure: Clinical laboratory tests
timeFrame: every 4 weeks
Secondary outcomes:
measure: Changes in fasting blood glucose (FBG) from baseline to each visit (OC) and Week 52 (LOCF)
timeFrame: each visit (OC) and Week 52 (LOCF)
Other outcomes:
Locations:
city: Chubu Region
country: Japan
city: Kanto Region
country: Japan
city: Tohoku Region
country: Japan
Study officials:
References:
Clinical trial NCT01513018: Effects of High and Low Tidal Volumes on Arterial Oxygenation and Pulmonary Shunt During One-Lung Ventilation
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Postoperative Lung Injury
Keywords: OLV
one lung ventilation
Lead sponsor: The Cleveland Clinic
Sponsor class: OTHER
First posted: 2012-01-20
Enrollment: 100
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: CROSSOVER
Primary purpose: BASIC_SCIENCE

Brief summary: The ideal tidal volume (TV) during one-lung ventilation (OLV) remains controversial. High tidal volumes may increase the incidence of postoperative lung injury after thoracic surgery. The investigators thus evaluated the influence of low (5 ml/kg) and high (10 ml/kg) tidal volumes on arterial oxygenation and Intrapulmonary shunt during OLV.

One hundred patients scheduled for thoracic surgery were enrolled. During OLV, patients were randomly assigned to 30 minutes of ventilation with high TV (10 ml/kg with zero end-expiratory pressure (ZEEP)) at a rate of 10 breaths/minute or low tidal volume (5 ml/kg with 5 cm H2O positive end-expiratory pressure (PEEP)) at a rate of 20 breaths/minute. During the subsequent 30 minutes, each patient received the alternative management. Minute volume was thus kept constant during each experimental condition. Arterial blood partial pressures, hemodynamic responses, and ventilatory parameters were recorded. Results are presented as means ± SDs; P \< 0.05 was considered statistically significant.


Eligibility criteria: Inclusion Criteria:

* ASA I-III patients scheduled for lung resection surgery.

Exclusion Criteria:

* severe cardiovascular disease
* severe alteration of the preoperative pulmonary function, with FEV1 70-120% predicted and FEV1/FVC ≥ 70% predicted considered to be normal.

Primary outcomes:
measure: low (5ml/kg) tidal volume on arterial oxygenation
timeFrame: 30 minutes of ventillation
measure: high (10 ml/kg) tidal volumes on arterial oxygenation
timeFrame: 30 minutes of ventillation
measure: low (5 ml/kg)tidal volumes on Intrapulmonary shunt
timeFrame: 30 minutes of ventillation
measure: high (10 ml/kg) tidal volumes on Intrapulmonary shunt
timeFrame: 30 minutes of ventillation
Secondary outcomes:
Other outcomes:
Locations:
city: Debrecen
country: Hungary
facility: University of Debrecen, Medical and Health Science CenterDepartment of Anesthesiology and Intensive Care
Study officials:
affiliation: Klinikum Ludwigshafen
name: Tamás Végh, M.D.
role: PRINCIPAL_INVESTIGATOR
References:
Clinical trial NCT06793618: Effectiveness of the Z-Track Technique As a Pain-Reducing Strategy for Neonates During Intramuscular Injection: a Randomized Controlled Trial
Official title: Effectiveness of the Z-Track Technique As a Pain-Reducing Strategy for Neonates During Intramuscular Injection: a Randomized Controlled Trial
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Intramuscular Injection
Neonates
Neonatal Pain
Keywords: Pain
non-pharmacological pain managment
Lead sponsor: University of Baghdad
Sponsor class: OTHER
First posted: 2025-01-27
Enrollment: 147
Sex: ALL
Minimum age (years): 5
Maximum age (years): 2
Standard ages: CHILD
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: A randomized control trial with one intervention and one control group. post-test only
Primary purpose: SUPPORTIVE_CARE

Brief summary: A quantitative study, true experimental, posttest-only design has been used for the current study. one intervention (the Z-track technique) and one control group involved in the study. The primary outcome measure is the Neonatal/Infant Pain Scale to be used immediately after intramuscular injections to measure the pain level among neonates.


Eligibility criteria: Inclusion Criteria:

* Neonates delivered through cesarean section
* Apgar score of 8 or more
* Weight between 2500 - 3500 grams
* neonates receiving IM injections
* Males / females
* term neonates between 37th and 42nd week of gestation

Exclusion Criteria:

* Congenital anomalies
* neonates who received intramuscular injection such as the Hepatitis B vaccine
* Low birth weight
* Preterms
* Neural tube defects
* neonates who are of normal vaginal delivery

Primary outcomes:
measure: Neonatal/ Infant Pain Scale
timeFrame: from the process of enrollment at the post-natal ward until the IM injection is administered (usually takes less than 1 hour)
Secondary outcomes:
Other outcomes:
Locations:
city: Samawah
country: Iraq
facility: Feminine and Children Educational Hospital
state: Al-Muthanna
Study officials:
References:
Clinical trial NCT04343118: Benefit of Surgical Hardware Removal Following Clavicle Fracture
Official title: Do Patients Benefit From Elective Implant Removal Following Plate Osteosynthesis of Clavicle Fractures - a Prospective Trial
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Clavicle Fracture
Lead sponsor: Technical University of Munich
Sponsor class: OTHER
First posted: 2020-04-13
Enrollment: 30
Sex: ALL
Minimum age (years): 18
Maximum age (years): 100
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: PROBABILITY_SAMPLE
Study population: Patients requesting implant removal

Brief summary: Little is known about the beneficial aspects of elective implant removal following plate osteosynthesis of displaced clavicle fractures.

Detailed description: Elective implant removal accounts for up to 30% of all orthopaedic surgeries. While there is general acceptance about the need of implant removal for obvious reasons, such as infections or implant failure, little is known about the beneficial aspects in cases of minor reasons. Therefore, we initiated this study to define patients' benefit of elective implant removal following plate osteosynthesis of displaced clavicle fractures.

Patients and Methods Prospective evaluation of patients was conducted before implant removal and 6 weeks postoperative. Subjective and objective criteria included patients' satisfaction, pain rating on a visual analog scale (VAS) and active range of motion (ROM) pre- and 6 weeks postoperative. Functional scoring included the SPADI, DASH score, the Constant Score and the Munich Shoulder Questionnaire (MSQ).

Eligibility criteria: Inclusion Criteria:

* age \>18 years
* Radiologically consolidated clavicle fracture
* following ORIF using a superior anatomically preformed locking plate
* asking for elective implant removal
* written informed consent.

Exclusion Criteria:

* Pregnancy
* Under-aged
* Delinquent patients.

Primary outcomes:
measure: Shoulder function
timeFrame: 6 Week post surgery
Secondary outcomes:
Other outcomes:
Locations:
city: Munich
country: Germany
facility: Klinik und Poliklinik für Unfallchirurgie, Klinikum rechts der Isar
state: Bavaria
Study officials:
affiliation: Klinikum rechts der Isar, TU München
name: Chlodwig Kirchhoff, MD
role: PRINCIPAL_INVESTIGATOR
References:
citation: Wurm M, Beirer M, Zyskowski M, Volk C, Schwarz A, Biberthaler P, Kirchhoff C, Cronlein M. Does implant removal of superior clavicle plate osteosynthesis affect the functional outcome: a prospective trial. Arch Orthop Trauma Surg. 2022 Jan;142(1):139-144. doi: 10.1007/s00402-020-03669-z. Epub 2020 Nov 1.
Clinical trial NCT05875818: Comparison of Tele-rehabilitation Versus In-clinic Rehabilitation for Upper Limb Motor Function Stroke Patients
Official title: Comparison of Effects of Tele-rehabilitation Versus In-clinic Rehabilitation for Upper Limb Motor Function in Chronic Stroke Patients
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Stroke
Lead sponsor: Superior University
Sponsor class: OTHER
First posted: 2023-05-25
Enrollment: 68
Sex: ALL
Minimum age (years): 45
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: HEALTH_SERVICES_RESEARCH

Brief summary: To determine the effects of Tele-rehabilitation versus in-clinical rehabilitation for upper limb motor function and spasticity in chronic ischemic stroke patients.


Eligibility criteria: Inclusion Criteria:

* • Patients from both genders.

  * Patients with chronic ischemic stroke i.e. 6 months or more.
  * Patients with 45 years old and above.
  * On modified Ashworth scale, patient with limb spasticity equal to 2 or less than 2.
  * On Mini Mental State Examination (MMSE), patients with good cognitive function minimum 24 or more.

Exclusion Criteria:

* • Patients with any recurrent stroke history.

  * Cognitive deficit patients (on Folstein Mini Mental state Examination score of less than 24)
  * Patient having other neurological diseases.

Primary outcomes:
measure: Fugal Myer assessment scale (FMAS)
timeFrame: 6 Months
measure: Modified Ashworth Scale (MAS)
timeFrame: 6 Months
Secondary outcomes:
Other outcomes:
Locations:
city: Lahore
country: Pakistan
facility: Chaudary Muhammad Akram Teaching Hospital
state: Punjab
Study officials:
References:
Clinical trial NCT04035018: Effectiveness of Pharmacopuncture for Chronic Neck Pain
Official title: A Study on the Effectiveness of Pharmacopuncture for Chronic Neck Pain: A Protocol for a Pragmatic Randomized Controlled Trial
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Chronic Neck Pain
Lead sponsor: Jaseng Medical Foundation
Sponsor class: OTHER
First posted: 2019-07-29
Enrollment: 101
Sex: ALL
Minimum age (years): 19
Maximum age (years): 70
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: In this study, the investigators will evaluate the efficacy and safety of pharmacopuncture therapy for chronic neck pain compared to physical therapy.

Detailed description: This study is prgmatic RCT of pharmacopuncture therapy for chronic neck pain compared to physical therapy.

Eligibility criteria: Inclusion Criteria:

* Neck pain more than 6 months
* VAS of neck pain more than 5
* Age between 17 and 70 years old
* Participants who wrote informed consent

Exclusion Criteria:

* Migration of cancer reaching to spine, fracture of spine
* Progressive neurologic deficits or severe neurologic deficits
* Cancer, fibromyalgia, RA, or goat
* Stroke, MI, kidney disease, dimentia, diabetic neuropathy, or epilepsy
* Participants taking steroid, immunosuppressant, or psychotropic medication
* Hemorrhagic disease, severe diabetes or taking anticoagulant drug
* Participants who took NSAIDs or pharmacopuncture within 1 week
* Pregnant or lactating women
* Participants who had undergone cervical surgery within 3 months
* Participants who had participated in other clinical trial within 1 month, or have plan for participation in other trial during follow up period of this trial
* Participants who can not write informed consent
* Participants who is difficult to participate in the trial according to investigator's decision

Primary outcomes:
measure: Visual analogue scale of neck pain
timeFrame: week 6
Secondary outcomes:
Other outcomes:
Locations:
city: Seoul
country: Korea, Republic of
facility: Jaseng Hospital of Korean Medicine
state: Gangnam-Gu
city: Bucheon
country: Korea, Republic of
facility: Bucheon Jaseng Hospital of Korean Medicine
state: Gyeonggi Province
city: Busan
country: Korea, Republic of
facility: Haeundae Jaseng Hospital of Korean Medicine
city: Daejeon
country: Korea, Republic of
facility: Daejeon Jaseng Hospital of Korean Medicine
Study officials:
affiliation: Jaseng Hospital of Korean Medicine
name: In-Hyuk Ha
role: PRINCIPAL_INVESTIGATOR
References:
citation: Park KS, Kim S, Kim C, Seo JY, Cho H, Kim SD, Lee YJ, Lee J, Ha IH. A Comparative Study of the Effectiveness of Pharmacopuncture Therapy for Chronic Neck Pain: A Pragmatic, Randomized, Controlled Trial. J Clin Med. 2021 Dec 21;11(1):12. doi: 10.3390/jcm11010012.
Clinical trial NCT00371618: IPM Procedures With or Without Fluoroscopy: Outcome Comparison
Official title: Comparison of Outcomes of Interventional Pain Management Procedures Performed With or Without Fluoroscopy: A Retrospective Analysis
Study type: OBSERVATIONAL
Overall status: WITHDRAWN
Conditions: Low Back Pain
Neck Pain
Keywords: Fluoroscopy
Interventional Pain Management Procedures
Lead sponsor: Pain Management Center of Paducah
Sponsor class: OTHER
First posted: 2006-09-04
Enrollment: 0
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: CASE_ONLY
Time perspective: RETROSPECTIVE
Sampling method: PROBABILITY_SAMPLE
Study population: currently enrolled patients

Brief summary: To determine clinically significant improvement in the patients undergoing procedures under fluoroscopy.

To evaluate and compare the adverse event profile in both groups

Detailed description: For the target delivery of injectate, it is believed that fluoroscopy is mandatory. However, there is a view among some professionals that a procedure may be performed without fluoroscopy as effectively as under fluoroscopy. The outcomes among the two groups of patients have not been studied

Eligibility criteria: Inclusion Criteria:

Patients who have undergone the following procedures:

Cervical facet joint nerve blocks, thoracic facet joint nerve blocks, lumbar facet joint nerve blocks, lumbar interlaminar epidural steroid injections, cervical Interlaminar epidural steroid injections

During 1998 to 2001 and 2004 to 2005

-

Exclusion Criteria: Non-availability of appropriate data

Primary outcomes:
measure: To demonstrate clinically significant improvement in the patients undergoing procedures under fluoroscopy.
measure: To evaluate and compare the adverse event profile in both groups
Secondary outcomes:
Other outcomes:
Locations:
city: Paducah
country: United States
facility: Ambulatory Surgery Center
state: Kentucky
Study officials:
affiliation: Ambulatory Surgery Center
name: Laxmaiah Manchikanti, MD
role: PRINCIPAL_INVESTIGATOR
References:
Clinical trial NCT06984913: Ultrasound-Guided Versus Brainlab Navigation Sphenopalatine Ganglion Block in Functional Endoscopic Sinus Surgery
Official title: Ultrasound-Guided Versus Brainlab Navigation Sphenopalatine Ganglion Block in Functional Endoscopic Sinus Surgery: A Randomized Clinical Trial
Study type: INTERVENTIONAL
Overall status: RECRUITING
Phase: NA
Conditions: Ultrasound
Brainlab Navigation
Sphenopalatine Ganglion Block
Functional Endoscopic Sinus Surgery
Lead sponsor: Tanta University
Sponsor class: OTHER
First posted: 2025-05-22
Enrollment: 60
Sex: ALL
Minimum age (years): 18
Maximum age (years): 65
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: This study compares ultrasound-guided and Brainlab navigation sphenopalatine ganglion block (SPGB) in functional endoscopic sinus surgery (FESS).

Detailed description: Functional endoscopic sinus surgery (FESS) is the treatment modality of choice for the inflammatory disease of paranasal sinuses.

Sphenopalatine ganglion block (SPGB) is a regional analgesic technique that can be used as an alternative approach to reduce blood loss and improve the operative field during FESS without the need for hypotensive agents.

Ultrasound (US)-guided nerve block is a well-established technique in regional anesthesia and offers the advantage of real-time visualization of neural and vascular structures.

Eligibility criteria: Inclusion Criteria:

* Age from 18 to 65 years.
* Both sexes.
* American Society of Anesthesiologists (ASA) physical status I-II.
* Patients undergoing functional endoscopic sinus surgery under general anesthesia.

Exclusion Criteria:

* Patients having a history of severe renal, hepatic, respiratory, cardiac disease, or a neurological condition.
* Drug or alcohol abuse.
* Chronic pain requires major analgesics, sedatives, or corticosteroids.
* Pregnant and lactating women.
* Hypersensitivity to local anesthetic agents.

Primary outcomes:
measure: Surgical field condition
timeFrame: 135 min post-procedure
Secondary outcomes:
measure: Mean arterial pressure
timeFrame: 135 min post-procedure
measure: Heart rate
timeFrame: 135 min post-procedure
measure: Intraoperative fentanyl consumption
timeFrame: Intraoperatively
measure: Intraoperative nitroglycerine consumption
timeFrame: Intraoperatively
measure: Degree of pain
timeFrame: 24 hours postoperatively
measure: Time to extubation
timeFrame: One hour postoperatively
measure: Recovery time
timeFrame: One hour postoperatively
measure: Incidence of adverse events
timeFrame: 24 hours postoperatively
Other outcomes:
Locations:
city: Tanta
country: Egypt
facility: Tanta University
state: El-Gharbia
Study officials:
References: